Globe Newswire
Global Footwear Industry
Abstract: – The global market for Footwear is projected to reach US$ 403. 2 billion by 2025, driven by new design trends and rising discretionary spending among the expanding base of middle class population.New York, April 07, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Footwear Industry” – https://www.reportlinker.com/p05151473/?utm_source=GNW Other major factors driving growth in the market include rise of smart concepts such as connected fabrics, footwear internet of things and material innovations including leather alternatives derived from fruit, palm, mushroom, pineapple and sericin. 3D printing is increasingly becoming mainstay of shoe manufacturing with the technology enabling manufacturers to cope with the overwhelming demand for a wide variety of shoe designs and mass customization. In the casual footwear market, timeless classics are making a comeback with women preferring simple classic black pair of shoes with medium heels which serve as perfect accessory for almost any outfit. From office to date to gym, people are buying footwear for every occasion. Shoes are increasingly becoming expressive of one’s personality, a trend that is driving up the concept of “investment shoes” defined as expensive shoes with luxury materials such as premium leather. Sneakers are rapidly going from street fashion into the sophisticated corporate boardrooms. In a landmark change in consumer behavior, men are spending more shoes and are preferring color over the conventional black. Consumerism is the key reason behind the growing per capita consumption of footwear worldwide. Other noteworthy trends in the market include growing popularity of dimethylformamide (DMF) free PU synthetic leather chemicals in the manufacture of footwear supported by benefits such as design freedom and environmental benefits; increased consumer involvement in sports and fitness activities and the ensuing demand for athletic footwear; and growing commercial value of eco-friendly footwear and increased research and development interest in plant-based leathers. The rise of multifunctional fashion is driving the prominence of convertible shoes interchangeable with a wide range of dresses. Also, emerging and established footwear brands are resorting to celebrity endorsements to help spur sales of non-athletic footwear. – Athletic shoes constitute one of the leading categories of the footwear market, supporting the active lifestyles of consumers who are increasingly getting ’sporty’. Key footwear brands within the segment include Nike and adidas as well as small-sized brands and companies that offer a wide range of footwear for diverse customer segments. Companies operating within the segment are also constantly innovating on functionality, performance and comfort to evade competition. From golfing to running, sports have become highly intertwined with consumers’ day-to-day lifestyles and are not considered just recreation. Growing awareness of keeping fit, both among the ageing and the youngsters, is bolstering healthy growth, coupled with rising average per capita income. In what is being considered as a relatively new trend, gifting of athletic footwear on prominent occasions and holidays is fast catching up across the US and other markets. In the past couple of years, footwear has earned itself as one of the most sought after holiday gifts, thereby making it one of the top five preferences for local consumers. This particular trend is expected to boost growth of the local footwear industries in the US and developed European market. The United States, in value terms, represents the single largest market worldwide supported by robust demand for athletic and sporting footwear as a result of their acceptance as part of casual dressing among men and women. Asia-Pacific including China is a major market led by factors such as growing population, apparel needs and a parallel increase in demand for affordable mass-market footwear; westernization of lifestyles among young affluent people and a parallel increase in demand for sneakers; and growing preference for high-fashion and branded footwear among the middle class population. – Select Competitors (Total 470 Featured) – adidas AG Reebok International Limited ANTA Sports Products Limited ASICS Corporation Bata Bata India Ltd. Caleres Deckers Brands ECCO Sko A/S Feng Tay Enterprises Co., Ltd. Geox s.p.a Gucci Group NV Kenneth Cole Productions, Inc. LaCrosse Footwear, Inc. Nike Inc. Nine West Power Athletics Limited Puma SE RG Barry Corporation Timberland LLC Vans, Inc. Weyco Group Inc. Wolverine World Wide, Inc. Read the full report: https://www.reportlinker.com/p05151473/?utm_source=GNW I. METHODOLOGY II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Influencer Market Insights World Market Trajectories Impact of Covid-19 and a Looming Global Recession EXHIBIT 1: The World of Clinical Microbiology Gains Sudden Prominence as Scientists Mobilize United Efforts to Find Ways to Detect, Treat & Vaccinate People Against the Novel Coronavirus: Global Scale of Daily Testing Vs Confirmed Cases Per Million Clinical Microbiology: An Introduction Outlook: Evolutionary Battle against Microbes Drives Market Future Instant Detection of Pathogens : A New Epoch in the Fight for Survival Reagents Account for Major Share Asia-Pacific Drives Future Growth Recent Market Activity World Brands 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS Microbiology Laboratories Switch to Automation to Push Yields EXHIBIT 2: World Laboratory Automation Market in US$ Billion for Years 2018, 2020, 2022, 2024 & 2026 Clinical Microbiology Market Benefits from Digitalization and Robotization Trend Integration of Clinical Microbiology with Cloud Computing Artificial Intelligence Holds Positive Implications for Automation of Clinical Microbiology Advancements in Molecular Diagnostics Drive Market Growth Emerging Technologies in Clinical Microbiology Diagnostics Aim at Faster Diagnosis Technological Advances Crucial to Sustain Future Market Growth Rapid Diagnostics Bring in a Transformation Automated and Rapid Microbiological Tests Revolutionize Microbiological Testing Traditional Rapid Microbiological Tests Make Way for New, Probe Tests Antibiotic Resistant Bacteria Throws the Spotlight on Microbial Testing Research in Stem Cell Technology, and Regenerative Medicine Expand Growth Opportunities EXHIBIT 3: Stem Cell Banking Global Market Estimates and Forecasts in US$ Billion: 2020, 2022 & 2024 Greater Number of Tests for HIV and Sexually Transmitted Diseases Amplify Growth EXHIBIT 4: Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2018 EXHIBIT 5: Number of AIDS-Related Deaths (in Thousands) by Region for 2018 Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease Home HIV Testing Emerges as a Lucrative Option Increasing Incidence of Infectious Diseases Drives Growth EXHIBIT 6: Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %) EXHIBIT 7: Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %) Increasing Prevalence of Respiratory Infections Drive Growth EXHIBIT 8: Global Number of Deaths Caused Due to Communicable Diseases (In 000s) Influenza Boosts Rapid Test Prospects EXHIBIT 9: Flu Related CDC Estimates from October 2019-April4, 2020 Rise in Prevalence of COPD Augments Demand EXHIBIT 10: Global Prevalence of COPD by Age Group: Percentage of Men and Women Affected by the Condition Rise in Pollution Levels Trigger Increase in Respiratory Diseases EXHIBIT 11: World Ranking of Most Polluted Countries: 2019 EXHIBIT 12: Percentage Share Breakdown of Global Deaths Linked to Air Pollution Increase in Healthcare Spending in Emerging Markets to Propel Demand EXHIBIT 13: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023 Demographic Shifts & Societal Changes Drive Demand for Test Volumes EXHIBIT 14: Elderly Healthcare Expenditure as a % of GDP EXHIBIT 15: Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050 EXHIBIT 10: Life Expectancy at Age 60 and 80 Years: (2010-2015 ), (2020-2025) & (2045-2050) 4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 2: World Historic Review for Clinical Microbiology Instruments and Reagents by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 3: World 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 Table 4: World Current & Future Analysis for Instruments by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 5: World Historic Review for Instruments by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 6: World 15-Year Perspective for Instruments by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 7: World Current & Future Analysis for Reagents by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 8: World Historic Review for Reagents by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 9: World 15-Year Perspective for Reagents by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 10: World Current & Future Analysis for Respiratory Diseases by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 11: World Historic Review for Respiratory Diseases by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 12: World 15-Year Perspective for Respiratory Diseases by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 13: World Current & Future Analysis for Bloodstream Infections by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 14: World Historic Review for Bloodstream Infections by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 15: World 15-Year Perspective for Bloodstream Infections by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 16: World Current & Future Analysis for Gastrointestinal Diseases by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 17: World Historic Review for Gastrointestinal Diseases by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 18: World 15-Year Perspective for Gastrointestinal Diseases by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 19: World Current & Future Analysis for Sexually Transmitted Diseases by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 20: World Historic Review for Sexually Transmitted Diseases by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 21: World 15-Year Perspective for Sexually Transmitted Diseases by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 22: World Current & Future Analysis for Urinary Tract Infections by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 23: World Historic Review for Urinary Tract Infections by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 24: World 15-Year Perspective for Urinary Tract Infections by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 25: World Current & Future Analysis for Other Disease Areas by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 26: World Historic Review for Other Disease Areas by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 27: World 15-Year Perspective for Other Disease Areas by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 28: World Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 29: World Historic Review for Hospitals & Diagnostic Centers by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 30: World 15-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 31: World Current & Future Analysis for Custom Lab Service Providers by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 32: World Historic Review for Custom Lab Service Providers by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 33: World 15-Year Perspective for Custom Lab Service Providers by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 Table 34: World Current & Future Analysis for Academic & Research Institutes by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 35: World Historic Review for Academic & Research Institutes by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 36: World 15-Year Perspective for Academic & Research Institutes by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 III. MARKET ANALYSIS UNITED STATES Market Overview EXHIBIT 16: Healthcare Spending as a % of GDP in the US: 2010-2020 COVID-19 Pandemic: US Emerges as a Major Market for COVID-19 Tests Table 37: USA Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product – Instruments and Reagents – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 38: USA Historic Review for Clinical Microbiology Instruments and Reagents by Product – Instruments and Reagents Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 39: USA 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product – Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 Table 40: USA Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area – Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 41: USA Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area – Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 42: USA 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area – Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027 Table 43: USA Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use – Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 44: USA Historic Review for Clinical Microbiology Instruments and Reagents by End-Use – Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 45: USA 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use – Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027 CANADA Table 46: Canada Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product – Instruments and Reagents – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 47: Canada Historic Review for Clinical Microbiology Instruments and Reagents by Product – Instruments and Reagents Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 48: Canada 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product – Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 Table 49: Canada Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area – Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 50: Canada Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area – Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 51: Canada 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area – Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027 Table 52: Canada Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use – Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 53: Canada Historic Review for Clinical Microbiology Instruments and Reagents by End-Use – Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 54: Canada 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use – Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027 JAPAN Market Overview Covid-19 Testing Market in Japan Demographics Drive Market Growth EXHIBIT 17: Breakdown of Population by Age Group in Japan: 2010, 2020, and 2025 Market Analytics Table 55: Japan Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product – Instruments and Reagents – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 56: Japan Historic Review for Clinical Microbiology Instruments and Reagents by Product – Instruments and Reagents Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 57: Japan 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product – Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 Table 58: Japan Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area – Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 59: Japan Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area – Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 60: Japan 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area – Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027 Table 61: Japan Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use – Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 62: Japan Historic Review for Clinical Microbiology Instruments and Reagents by End-Use – Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 63: Japan 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use – Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027 CHINA Market Overview Covid-19 Testing Market Market Analytics Table 64: China Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product – Instruments and Reagents – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 65: China Historic Review for Clinical Microbiology Instruments and Reagents by Product – Instruments and Reagents Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 66: China 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product – Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 Table 67: China Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area – Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 68: China Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area – Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 69: China 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area – Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027 Table 70: China Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use – Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 71: China Historic Review for Clinical Microbiology Instruments and Reagents by End-Use – Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 72: China 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use – Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027 EUROPE Market Overview COVID-19 Pandemic Propels Demand Growth in Clinical Diagnostics Automation Rise in Automated, and Rapid Tests in Clinical Applications Ageing Demography: An Opportunity Indicator Market Analytics Table 73: Europe Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Geographic Region – France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR Table 74: Europe Historic Review for Clinical Microbiology Instruments and Reagents by Geographic Region – France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 75: Europe 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Geographic Region – Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 Table 76: Europe Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product – Instruments and Reagents – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 77: Europe Historic Review for Clinical Microbiology Instruments and Reagents by Product – Instruments and Reagents Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 78: Europe 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product – Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 Table 79: Europe Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area – Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 80: Europe Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area – Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 81: Europe 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area – Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027 Table 82: Europe Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use – Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 83: Europe Historic Review for Clinical Microbiology Instruments and Reagents by End-Use – Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 84: Europe 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use – Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027 FRANCE Table 85: France Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product – Instruments and Reagents – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 86: France Historic Review for Clinical Microbiology Instruments and Reagents by Product – Instruments and Reagents Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 87: France 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product – Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 Table 88: France Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area – Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 89: France Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area – Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 90: France 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Disease Area – Percentage Breakdown of Value Sales for Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas for the Years 2012, 2020 & 2027 Table 91: France Current & Future Analysis for Clinical Microbiology Instruments and Reagents by End-Use – Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 92: France Historic Review for Clinical Microbiology Instruments and Reagents by End-Use – Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 93: France 15-Year Perspective for Clinical Microbiology Instruments and Reagents by End-Use – Percentage Breakdown of Value Sales for Hospitals & Diagnostic Centers, Custom Lab Service Providers and Academic & Research Institutes for the Years 2012, 2020 & 2027 GERMANY Table 94: Germany Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Product – Instruments and Reagents – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 95: Germany Historic Review for Clinical Microbiology Instruments and Reagents by Product – Instruments and Reagents Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Table 96: Germany 15-Year Perspective for Clinical Microbiology Instruments and Reagents by Product – Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 Table 97: Germany Current & Future Analysis for Clinical Microbiology Instruments and Reagents by Disease Area – Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR Table 98: Germany Historic Review for Clinical Microbiology Instruments and Reagents by Disease Area – Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections and Other Disease Areas Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR Please contact our Customer Support Center to get the complete Table of ContentsRead the full report: https://www.reportlinker.com/p05151473/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001